Résultats de la recherche - 6 results
Clinical Evolution and Disease Burden in Belgian Cystic Fibrosis Patients: effect of Newborn Screening?
meconium ileus (MI), newborn screening (NBS) and clinical diagnosis (non- NBS) at 1-, 2- and 6 years of age.Methods: We conducted a retrospective observational cohort study based on data collected from the ...
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
infection were age >40 years, at least one F508 del mutation and pancreatic insufficiency.Overall, 23.7% of pwCF were admitted to hospital, 2.5% of those to intensive care, and regretfully 11 (1.4%) died. ...
Annual Report Belgian Cystic Fibrosis Registry 2018
in 2018, among them five adults, with a median age at diagnosis of 9.8 months and age range from birth to 70.6 years. All the newly diagnosed patients were genotyped; 18 had sweat chloride values > ...
Annual Report Belgian Cystic Fibrosis Registry 2017
diagnosis. There were 38 newly diagnosed patients in 2017, among them two adults, with a median age at diagnosis of 5.4 months with a range from birth to 60.4 years. All the newly diagnosed patients were ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
mutation (homozygous or heterozygous), and Pa colonization. RESULTS: Median FEV at the year of diagnosis (index year) was significantly lower in patients with ABPA. The median of cumulative values of FEV and ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
people with CF from an ethnic minority are at more risk of severe infection with SARS-CoV-2. Health Topics: COVID-19 Cystic fibrosis Cystische fibrose Fibrose cystique Service: Étude des soins de santé ...